
On World Hepatitis Day, health experts are focusing on a group that often slips through the cracks: seafarers. These workers spend months at sea, far from routine medical care. That isolation makes them especially vulnerable to hepatitis B and C, infections that can quietly damage the liver for years.
Dr. Ananya Sharma, a hepatologist at a Mumbai-based hospital, explains that seafarers are at higher risk because of limited access to preventive care. "They cannot just walk into a clinic. By the time symptoms show, the disease has often progressed," she says.
Vaccination against hepatitis B is highly effective, but many seafarers never receive it. The problem is compounded by irregular portside health camps and a lack of awareness. Onboard medical kits rarely include testing kits for hepatitis, and crew members may not report symptoms for fear of being deemed unfit for duty.
Port health authorities in Indian cities have begun offering free screening camps, but coverage remains patchy. The International Seafarers' Welfare and Assistance Network has called for mandatory hepatitis B vaccination as part of pre-employment medical checks.
India has set a target to eliminate hepatitis C by 2030. The Ministry of Health runs national viral hepatitis control programs that provide free testing and treatment in public hospitals. On July 28, the Press Information Bureau confirmed that Ripon Buildings in Chennai were lit green as a symbol of solidarity with the global campaign.
Despite these efforts, awareness remains low. Many people still confuse hepatitis with jaundice and delay seeking help. Doctors stress that early detection can prevent cirrhosis and liver cancer.
Hepatitis B and C are often called silent epidemics because they show few symptoms until the liver is severely damaged. Fatigue, dark urine, and abdominal pain are late signs. The World Health Organization recommends that all adults get tested at least once, especially those in high-risk occupations like seafaring.
Simple blood tests can confirm infection. Treatment for hepatitis C now involves just 8-12 weeks of oral medication, with cure rates above 95%. For hepatitis B, antiviral drugs can control the virus and prevent complications.
What happens next? Indian port cities are expected to expand screening camps in the coming months. The focus will be on reaching mobile populations like seafarers before the disease takes hold.